Karim Amighi - Düsseldorf, 07, Germany (2 books)
PDF) Recent Developments in Inhaled Triazoles Against Invasive Pulmonary Aspergillosis | Karim Amighi - Academia.edu
Editorial board - International Journal of Pharmaceutics: X | ScienceDirect.com by Elsevier
Faculté de Pharmacie
Karim Amighi - NOWRUZ:Iranian Nation thanks Donald Trump... | Facebook
Karim Amighi - Ba Laanate bar harchi Molla. Irani shad bash! | Facebook
Karim Amighi - Ba Laanate bar harchi Molla. Irani shad bash! | Facebook
About Inhatarget Therapeutics : Mission and Expertise
PDF) Peroral Sustained-Release Film-Coated Pellets as a Means to Overcome Physicochemical and Biological Drug-Related Problems. I. In Vitro Development and Evaluation | Karim Amighi - Academia.edu
ULB - Université libre de Bruxelles - Paroles de chercheurs Un nouveau médicament délivré par voie pulmonaire avec Karim Amighi, Laboratoire de pharmacie galénique et de biopharmacie Le Laboratoire de pharmacie galénique
Karim AMIGHI: LA DÉLIVRANCE PULMONAIRE - YouTube
Elena Menchi - DDL
Rémi ROSIÈRE | Inhalation (DPI) Formulation Scientist | PhD, PharmD | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile
Karim Amighi (@Amighikarim) / Twitter
European Respiratory Cluster Antwerp
PDF) Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties | Karim Amighi - Academia.edu
Karim AMIGHI | PhD Pharmaceutical sciences | Université Libre de Bruxelles, Brussels | ULB | Laboratory of Pharmaceutics and Biopharmaceutics (ULBGAL) | Research profile
Editorial Board - International Journal of Pharmaceutics: X - Journal - Elsevier
About Inhatarget Therapeutics : Mission and Expertise
Frederic OPRENYESZK | Scientific Researcher - R&D Co-manager | Doctor of biomedecine and pharmaceutical science | Research profile
100+ "Amighi" profiles | LinkedIn
100+ "Amighi" profiles | LinkedIn
